Ethical and social recognition of participation in drug clinical trials: French public views on financial compensation for participants
Laure Peyro-Saint-Paul, Cathy Gaillard, Célia Berchi, Clément Gakuba, Charlotte Gourio, Guillaume Grandazzi, Michael Joubert, Sylvie Brucato · 2026
Read Ethical and social recognition of participation in drug clinical trials: French public views on financial compensation for participants by Laure Peyro-Saint-Paul, Cathy Gaillard, Célia Berchi, Clément Gakuba, Charlotte Gourio, Guillaume Grandazzi, Michael Joubert, Sylvie Brucato (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0343321.txt.
Description
Laure Peyro-Saint-Paul and colleagues surveyed the French public about a delicate ethics question: should people who volunteer for drug trials be paid, and how much? Their 2026 exploratory study gathered sixty-five respondents in clinics and online, presented three fictional trials varying in risk, burden, and personal benefit, and asked what compensation seemed fair.
Three quarters backed payment in principle. The strongest triggers were facing a new experimental drug, invasive procedures, and lost income. Support and suggested amounts rose with burden: highest for a demanding, uncertain trial with some benefit, lowest for an easy one. The survey feeds a larger French project building a decision tool so sponsors and ethics committees price participation fairly without dangling coercive sums.
Catalog record
| CREATOR | Laure Peyro-Saint-Paul, Cathy Gaillard, Célia Berchi, Clément Gakuba, Charlotte Gourio, Guillaume Grandazzi, Michael Joubert, Sylvie Brucato |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34785 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |